Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
TELUS demonstrated strong financial performance with industry-leading free cash flow growth, customer additions, and improved EBITDA margins. The Q&A section highlighted positive future prospects, including CapEx reductions, margin expansions, and significant developments in AI and data centers. While some uncertainties exist, particularly in market pressures and wireline data revenue, the overall sentiment remains positive due to strategic investments and operational efficiencies.
Free Cash Flow Growth Industry-best free cash flow growth of 19% year-over-year, attributed to operational excellence and cost efficiency.
Customer Growth Achieved industry-leading customer growth of 262,000, including 12,000 mobile phone net additions and 229,000 connected device net additions, supported by TELUS' PureFiber and 5G+ broadband networks.
Network Revenue Increased by 1% year-over-year, driven by moderating ARPU decline and positive growth trends.
TELUS Health Revenue and EBITDA Service revenue and adjusted EBITDA grew by 11% year-over-year, supported by strategic investments, product innovation, and cost efficiencies.
TELUS Digital Revenue Revenue grew by 3% in U.S. dollars, with adjusted EBITDA increasing by 2% year-over-year, reflecting operational expense efficiencies.
Net Debt-to-EBITDA Ratio Improved to 3.5x from 3.9x year-over-year, reflecting strong free cash flow generation and deleveraging efforts.
Cash from Operations Generated more than $1 billion in the first quarter, contributing to industry-leading free cash flow.
Fixed Data Service Revenue Increased by 1% year-over-year, driven by residential Internet subscriber growth and higher revenue per customer.
Adjusted EBITDA Margin Expanded by 80 basis points to 44.4%, reflecting cost efficiency programs and synergies from TELUS Digital privatization.
AI-Driven Revenue Growth Achieved 22% year-over-year growth in AI-driven revenue, showcasing momentum in AI strategy.
TELUS Health: Achieved service revenue and adjusted EBITDA growth of 11%, marking the 15th straight quarter of double-digit adjusted EBITDA growth. TELUS Health is now generating over $2 billion in annual revenue and targeting EBITDA of over $400 million in 2026. The business is also generating $200 million of simple free cash flow in 2026.
TELUS Digital: Delivered strong double-digit revenue growth of 22% in Q1 2026. The sovereign AI factory in Rimouski is sold out, and a second facility in Kamloops is coming online soon. TELUS Digital is targeting $2 billion in revenue by 2028.
Customer Growth: Achieved industry-leading customer growth of 262,000, including 12,000 mobile phone net additions and 229,000 connected device net additions, supported by PureFiber and 5G+ broadband networks.
Global Expansion in Health: TELUS Health now covers nearly 170 million lives globally, positioning it as a leader in workforce digital health solutions.
Cost Efficiency: Achieved industry-best free cash flow growth of 19% and annual cash synergies of approximately $150 million to $200 million from TELUS Digital integration.
Operational Excellence: TELUS achieved an industry-low CapEx intensity while maintaining world-leading broadband connectivity. The copper-to-fiber transition is generating substantial real estate opportunities valued at $4 billion.
Strategic Partnerships for TELUS Health: Exploring strategic partnerships to accelerate growth and unlock value, with over 75 inbound inquiries received.
AI and Digital Transformation: TELUS Digital is focusing on AI transformations and customer experience leadership, leveraging its sovereign AI factories and integrated AI solutions.
Competitive Dynamics: TELUS faces challenges in maintaining its premium brand amidst competitive pricing pressures in the telecom market. The company has had to focus on preserving brand value while responding to aggressive pricing strategies from competitors.
Economic and Market Conditions: TELUS acknowledges the dynamic and ever-changing telecom market, which includes economic uncertainties that could impact revenue growth and operational stability.
Regulatory and Macroeconomic Headwinds: The company has faced significant regulatory and macroeconomic challenges since 2022, which continue to pose risks to its operations and financial performance.
Strategic Execution Risks: TELUS is undergoing strategic initiatives such as asset monetization, AI integration, and health business partnerships. These complex processes carry execution risks, including potential delays or failure to achieve expected synergies and financial outcomes.
Supply Chain and Infrastructure Expansion: The expansion of AI factories and broadband networks requires significant investment and operational efficiency. Any delays or cost overruns in these projects could adversely affect TELUS' financials and strategic goals.
Foreign Exchange Impact: TELUS Digital's revenue was negatively impacted by unfavorable foreign exchange rates, which could continue to affect financial performance if not mitigated.
Customer Retention and Revenue Growth: The company is focusing on bundling services to reduce churn and increase revenue per household. However, failure to effectively execute this strategy could impact customer retention and revenue growth.
Revenue Growth: TELUS Health is targeting EBITDA of over $400 million in 2026 and more than $200 million of simple free cash flow in 2026. TELUS Digital and TELUS Business Solutions aim for a revenue target of approximately $2 billion by 2028, driven by AI capabilities.
Free Cash Flow: TELUS projects free cash flow of approximately $2.45 billion in 2026, with a minimum 10% compounded annual growth rate through 2028.
Capital Expenditures: Capital expenditures are expected to moderate, with an industry-leading CapEx intensity ratio trending from 12% towards approximately 10%.
Debt Reduction: TELUS aims to achieve a net debt-to-EBITDA leverage ratio of 3.3x or lower by the end of 2026 and 3.0x or better by the end of 2027.
Asset Monetization: TELUS plans to monetize $7 billion of assets, including real estate and copper assets, with 77% of the PureFiber build being self-funded by these monetizations.
AI and Digital Expansion: TELUS Digital is expanding its AI capabilities, targeting double-digit revenue growth and leveraging its sovereign AI factories to meet market demand. The Rimouski AI factory is sold out, and a second facility in Kamloops will come online soon.
Market Trends: TELUS anticipates stabilization in competitive dynamics and a gradual retrenchment from aggressive pricing in the industry.
Dividend Maintenance: TELUS continues to maintain its dividend at the current level.
DRIP Discount Reduction: In the first quarter, TELUS reduced its DRIP (Dividend Reinvestment Plan) discount to 1.75% from 2%. Further reductions are planned through 2026 and into 2027, with the full removal taking effect by the end of 2027.
TELUS demonstrated strong financial performance with industry-leading free cash flow growth, customer additions, and improved EBITDA margins. The Q&A section highlighted positive future prospects, including CapEx reductions, margin expansions, and significant developments in AI and data centers. While some uncertainties exist, particularly in market pressures and wireline data revenue, the overall sentiment remains positive due to strategic investments and operational efficiencies.
TELUS shows strong strategic initiatives with EBITDA growth, stable CapEx, and plans for cash flow expansion. The Terrion partnership and AI revenue growth strategy are positive indicators. Despite slight ARPU challenges, TELUS is leveraging AI and bundling to counteract pressure. The Q&A reveals a proactive approach to market dynamics and financial management, including effective lease restructuring. Overall, the earnings call reflects a positive outlook, with strategic growth in health services and internet expansion, likely leading to a stock price increase.
The earnings call highlights TELUS's robust customer growth, strategic acquisitions, and positive free cash flow guidance. Despite concerns about pricing and increased churn, the company is leveraging AI and strategic partnerships to address these issues. The 7% dividend increase and strategic deleveraging plans further bolster investor confidence. The Q&A session reveals no major negative surprises, and the optimistic guidance and strategic initiatives suggest a positive outlook for the stock price.
The earnings call highlighted several negative factors: decreased revenue, increased net debt, negative free cash flow, and significant foreign exchange impacts. Despite a slight increase in net profit and share buybacks, the challenges of high raw material prices, inflation, and tariffs overshadowed positives. The Q&A session reinforced concerns about economic volatility and sales policy issues. The company's cautious outlook, lowered sales growth, and adjusted gross profit margin further indicate a negative sentiment, leading to an expected stock price decline in the range of -2% to -8%.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.